Streptozotocin induced hyperglycaemia in the invertebrate diabetic model Bombyx mori

Abstract

Worldwide spread in the incidence of diabetes justified the need of extensive research in an appropriate model system to develop an effective treatment strategy for diabetology. In recent years, because of animal ethical issues and limitations, the silkworm (Bombyx mori) has emerged as a perfect invertebrate model for various biomedical experiments. However, there are several issues related to induce hyperglycaemia in the mammalian system that have not been studied in the silkworms. In the present study, we investigated the consequences of induced hyperglycaemia by oral and intravascular administration of streptozotocin (STZ) and glucose in the silkworms. Interestingly, results confirmed the competence of STZ to induce hyperglycaemia when administered through intravascular route, but suppress the glucose concentration if administrated orally in the silkworms. Comparatively, the severity of induced hyperglycaemia in the silkworms remained nearly the same in response to the oral and intravascular administration of glucose. Furthermore, prolonged administration of STZ has recorded negative effect on the growth rate of the silkworms, whereas a drastic decline in the same was reported in the silkworms administered with glucose. Notably, these results confirm that the response shown by the silkworms to STZ is very similar to that of mammals, making it an excellent model to study diabetic complications and consequences associated with STZ in diabetology.